Induction of apoptosis by selenite and selenodiglutathione in HL-60 cells: correlation with cytotoxicity.
Effects of selenite and selenodiglutathione, an initial metabolite of selenite, on the induction of apoptosis and cytotoxicity were investigated in human promyelocytic leukemia HL-60 cells. Treatment of selenite or selenodiglutathione resulted in concentration-dependent cytotoxicity, measured by lactate dehydrogenase leakage assay, and by tetrazolium salt reduction assay. Selenodiglutathione has been shown to exert more cytotoxic effect than selenite in both assay systems. Time-course study of cellular selenium uptake suggests that the higher cytotoxicity of selenodiglutathione be largely due to faster and greater selenium uptake rate. Treatment with selenite or selenodiglutathione also induced apoptosis in a dose-dependent manner, as detected by enzyme-linked immunosorbent assay and by DNA fragmentation assay. The dose-response data of apoptosis induced by selenite or selenodiglutathione were similar to those of cytotoxicity, implicating a relationship between the induction of apoptosis and cytotoxicity. Zn, which is a well-known inhibitor of apoptosis, dose-dependently blocked not only the induction of apoptosis, but also the membrane damage induced by selenium, corroborating this hypothesis. It was noted that the inhibition of apoptosis by Zn exerted little protective effect on cytotoxicity at higher concentrations of selenium, compared with a perfect protective effect at low concentration of selenium. These results suggest that cytotoxicity induced by selenium may be partially correlated with apoptosis.
Cho
D Y
DY
Department of Biological Sciences, Korea Advanced Institute of Science and Technology, South Korea.
Jung
U
U
Chung
A S
AS
D017209:Apoptosis; D004305:Dose-Response Relationship, Drug; D005978:Glutathione / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology; D018922:HL-60 Cells; D006801:Humans; D016566:Organoselenium Compounds / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D018038:Sodium Selenite / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D013997:Time Factors; D015032:Zinc / Q000494:pharmacology
D016566:Organoselenium Compounds; C017710:selenodiglutathione; D005978:Glutathione; D018038:Sodium Selenite; D015032:Zinc